Pleno is developing a diagnostic platform that will make regular liquid biopsy testing like Early Cancer Screening and Minimal Residual Disease monitoring affordable and accessible to all. Through the use of advanced digital microfluidic technology combined with low-cost semiconductor manufacturing, we are able to deliver fully automated sample prep and detection in Point Of Care environments like retail/pharmacy clinics. This will completely change cancer as a disease - where you are able to detect it early in Stage 1/2 (90% survival rate) vs very late in Stage 3/4 (5% survival rate) as it is done today. The affordability and accessibility provided by our distributed instruments will enable all people from demographics, geographies and economic conditions to have access to this type of testing....
Pleno is developing a diagnostic platform that will make regular liquid biopsy testing like Early Cancer Screening and Minimal Residual Disease monitoring affordable and accessible to all. Through the use of advanced digital microfluidic technology combined with low-cost semiconductor manufacturing, we are able to deliver fully automated sample prep and detection in Point Of Care environments like retail/pharmacy clinics. This will completely change cancer as a disease - where you are able to detect it early in Stage 1/2 (90% survival rate) vs very late in Stage 3/4 (5% survival rate) as it is done today. The affordability and accessibility provided by our distributed instruments will enable all people from demographics, geographies and economic conditions to have access to this type of testing.
More information

Employees

Gavin Stone
Admin
Gavin Stone Product Successful serial entrepreneur with a background in electronic engineering and experience across semiconductor technology and genomics